Malignt pleuralt mesoteliom

Sajitha Sophia Sritharan, Jens Lundby Frandsen, Øyvind Omland, Jens Meldgaard Bruun

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1 Citationer (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. The disease is of importance, since the incidence in Denmark is increasing despite cessation of the use of asbestos in the 1980s. MPM has a long latency period, and the first symptom is often dyspnoea, typically caused by pleural effusion. The diagnosis is a challenge, because cytology often is non-conclusive, and thoracoscopy is needed to obtain biopsies for immunohistochemistry. The occupational history is important, since the patients are entitled to compensation. The treatment is often limited to palliation.

Bidragets oversatte titelMalignant pleural mesothelioma
OriginalsprogDansk
ArtikelnummerV06170439
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer15
Sider (fra-til)1-6
Antal sider6
ISSN0041-5782
StatusUdgivet - 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Malignt pleuralt mesoteliom'. Sammen danner de et unikt fingeraftryk.

Citationsformater